Lack of correlation between the reduction of serum immunoglobulin concentration and the CTG repeat expansion in patients with type 1 Dystrofia Myotonica

Journal of Neuroimmunology

Volumn 144, Issue 1-2, 2003, Pages 100-104

  Pan Hammarström, Qiang ^a   Wen, Sicheng ^a   Ghanaat Pour, Hamedeh ^a   Solders, Göran ^a   Forsberg, Håkan ^b   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

Author keywords

Dystrofia Myotonica; FcRn; Hypogammaglobulinemia; IgG subclasses

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3;

ADULT; AGED; ALPHA CHAIN; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL LEVEL; CHROMOSOME 19; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DMPK GENE; DNA FLANKING REGION; DYSTROFIA MYTONICA TYPE 1; FEMALE; GENE; GENETIC TRANSCRIPTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; TISSUE LEVEL; UNTRANSLATED REGION;

EID: 0142195837     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00271-6     Document Type: Article

References (31)

1. Aslanidis C., Jansen G., Amemiya C., Shutler G., Mahadevan M., Tsilfidis C., Chen C., Alleman J., Wormskamp N.G., Vooijs M., Buxton J., Johanson K., Smeets H.J.M., Lennon G.G., Carrano A.V., Kornelik R.G., Wieringa B., de Jong P.J. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature. 355:1992;548-551.
2. Brambell F.W.R., Hemmings W.A., Morris I.G. A theoretical model of g-globulin catabolism. Nature. 203:1964;1352-1355.
3. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., Hunter K., Stanton V.P., Thirion J.P., Hudson T., Sohn R., Zemelman B., Snell R.G., Rundle S.A., Crow S., Davies J., Shelburne P., Buxton J., Jones C., Juvonen V., Johanson K., Harper P.S., Shaw D.J., Housman D.E. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 68:1992;799-808.
4. Bruyland M., Lissens W., De Waele M., Demanet C. Hypo-IgG in myotonic dystrophy is due to a selective reduction of the IgG1-subclass serum level. Muscle Nerve. 17:1994;1233-1234.
5. Buxton J., Shelbourne P., Davies J., Jones C., Van Tongeren T., Aslanidis C., de Jong P., Jansen G., Anvret M., Riley B., Williamson R., Johanson K. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature. 355:1992;547-548.
6. Eriksson M., Ansved T., Edström L., Anvret M., Carey N. Simultaneous analysis of expression of the three myotonic dystrophy locus genes in adult skeletal muscle samples: the CTG expansion correlates inversely with DMPK and 59 expression levels, but not DMAHP levels. Hum. Mol. Genet. 8:1999;1053-1060.
7. Fu Y.H., Pizzuti A., Fenwick R.G. Jr., King J., Rajnarayan S., Dunne P.W., Dubel J., Nasser G.A., Ashizawa T., de Jong P., Wieringa B., Korneluk R., Perryman M.B., Epstein H.F., Caskey C.T. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 255:1992;1256-1258.
8. Ghetie V., Ward E.S. FcRn: the MHC class I-related receptor that is more than an IgG transporter. Immunol. Today. 18:1997;592-598.
9. Harley H.G., Brook J.D., Rundle S.A., Crow S., Reardon W., Buckler A.J., Harper P.S., Housman D.E., Shaw D.J. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature. 355:1992;545-546.
10. Hedberg B., Anvret M., Ansved T. CTG-repeat length in distal and proximal leg muscles of symptomatic and non-symptomatic patients with myotonic dystrophy: relation to muscle strength and degree of histopathological abnormalities. Eur. J. Neurol. 6:1999;341-346.
11. Israel E.J., Wilsker D.F., Hayes K.C., Schoenfeld D., Simister N.E. Increased clearance of IgG in mice that lack beta 2-microglobulin: possible protective role of FcRn. Immunology. 89:1996;573-578.
12. Jensen H., Jensen K.B., Jarnum S. Turnover of IgG and IgM in myotonic dystrophy. Neurology. 21:1971;68-71.
13. Junghans R.P., Ebralidze A., Tiwari B. Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy? A new hypothesis of long-range cis autosomal inactivation. Neurogenetics. 3:2001;59-67.
14. Kandil E., Egashira M., Miyoshi O., Niikawa N., Ishibashi T., Kasahara M., Miyosi O. The human gene encoding the heavy chain of the major histocompatibility complex class I-like Fc receptor (FCGRT) maps to 19q13.3. Cytogenet. Cell Genet. 73:1996;97-98.
15. Larsen B., Johnson G., van Loghem E., Marshall W.H., Newton R.M., Pryse-Phillips W., Skanes V. Immunoglobulin concentration and Gm allotypes in a family with thirty-three cases of myotonic dystrophy. Clin. Genet. 18:1980;13-19.
16. Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W., Naylor S.L., Day J.W., Ranum L.P. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 293:2001;864-867.
17. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barcelo J., O'Hoy K.et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 255:1992;1253-1255.
18. Mankodi A., Urbinati C.R., Yuan Q.P., Moxley R.T., Sansone V., Krym M., Henderson D., Schalling M., Swanson M.S., Thornton C.A. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum. Mol. Genet. 10:2001;2165-2170.
19. Nakamura A., Kojo T., Arahata K., Takeda S. Reduction of serum IgG level and peripheral T-cell counts are correlated with CTG repeat lengths in myotonic dystrophy patients. Neuromuscul. Disord. 6:1996;203-210.
20. Ranum L.P., Rasmussen P.F., Benzow K.A., Koob M.D., Day J.W. Genetic mapping of a second myotonic dystrophy locus. Nat. Genet. 19:1998;196-198.
21. Roberts D.F., Bradley W.G. Immunoglobulin levels in dystrophia myotonica. J. Med. Genet. 14:1977;16-19.
22. Rodewald R., Kraehenbuhl J.P. Receptor-mediated transport of IgG. J. Cell Biol. 99:1984;159s-164s.
23. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29:2001;40-47.
24. Simister N.E., Mostov K.E. An Fc receptor structurally related to MHC class I antigens. Nature. 337:1989;184-187.
25. Simister N.E., Rees A.R. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur. J. Immunol. 15:1985;733-738.
26. Sofue F., Suzumura A., Yamamoto H. IgG subclasses in the patients with myotonic dystrophy. Rinsho Shinkeigaku. 34:1994;788-792.
27. Story C.M., Mikulska J.E., Simister N.E. A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus. J. Exp. Med. 180:1994;2377-2381.
28. Waldmann T.A. Disorders of immunoglobulin metabolism. N. Engl. J. Med. 281:1969;1170-1177.
29. West A.P. Jr., Bjorkman P.J. Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor. Biochemistry. 39:2000;9698-9708.
30. Wochner R.D., Drews G., Strober W., Waldmann T.A. Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J. Clin. Invest. 45:1966;321-329.
31. Zinneman H.H., Rotstein J. A study of gamma globulins in dystrophia myotonica. J. Lab. Clin. Med. 47:1956;907-916.